atorvastatin has been researched along with g(m1) ganglioside in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ehrenstein, MR; Isenberg, DA; Jury, EC; Mauri, C | 1 |
Blank, N; Busse, F; Ho, AD; Kalden, JR; Krienke, S; Lorenz, HM; Schätz, B; Schiller, M | 1 |
2 other study(ies) available for atorvastatin and g(m1) ganglioside
Article | Year |
---|---|
Atorvastatin restores Lck expression and lipid raft-associated signaling in T cells from patients with systemic lupus erythematosus.
Topics: Adult; Aged; Anticholesteremic Agents; Atorvastatin; Cells, Cultured; Enzyme Activation; Female; G(M1) Ganglioside; Heptanoic Acids; Humans; Intracellular Fluid; Kinetics; Lupus Erythematosus, Systemic; Lymphocyte Specific Protein Tyrosine Kinase p56(lck); Male; Membrane Microdomains; Middle Aged; Protein Prenylation; Pyrroles; Receptors, Antigen, T-Cell; Signal Transduction; T-Lymphocyte Subsets | 2006 |
Atorvastatin inhibits T cell activation through 3-hydroxy-3-methylglutaryl coenzyme A reductase without decreasing cholesterol synthesis.
Topics: Antigen-Presenting Cells; Atorvastatin; Biomarkers; Calcium Signaling; Cell Membrane; Cell Proliferation; Cells, Cultured; Cholesterol; Extracellular Signal-Regulated MAP Kinases; G(M1) Ganglioside; Growth Inhibitors; Heptanoic Acids; HLA-DR Antigens; Humans; Hydroxymethylglutaryl-CoA-Reductases, NADP-dependent; Immunosuppressive Agents; Interferon-gamma; Jurkat Cells; Lymphocyte Activation; Phosphorylation; Protein Prenylation; Pyrroles; T-Lymphocytes | 2007 |